A detailed history of Bank Of America Corp transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 310,863 shares of PTCT stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
310,863
Previous 383,697 18.98%
Holding current value
$10.6 Million
Previous $11.2 Million 14.83%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.69 - $40.12 $1.8 Million - $2.92 Million
-72,834 Reduced 18.98%
310,863 $9.51 Million
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $2.84 Million - $3.76 Million
117,758 Added 44.28%
383,697 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$18.07 - $29.37 $3.46 Million - $5.62 Million
-191,350 Reduced 41.84%
265,939 $7.33 Million
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $441,370 - $645,667
10,925 Added 2.45%
457,289 $18.6 Million
Q1 2023

May 12, 2023

BUY
$38.16 - $48.86 $2.53 Million - $3.24 Million
66,344 Added 17.46%
446,364 $21.6 Million
Q4 2022

Feb 10, 2023

BUY
$33.53 - $54.79 $1.36 Million - $2.22 Million
40,457 Added 11.91%
380,020 $14.5 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $741,330 - $953,898
-17,714 Reduced 4.96%
339,563 $17 Million
Q2 2022

Aug 12, 2022

BUY
$25.6 - $45.23 $1.83 Million - $3.23 Million
71,482 Added 25.01%
357,277 $14.3 Million
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $78.3 Million - $105 Million
-2,348,348 Reduced 89.15%
285,795 $10.7 Million
Q4 2021

Feb 08, 2022

BUY
$35.36 - $41.86 $83.2 Million - $98.5 Million
2,352,106 Added 833.97%
2,634,143 $105 Million
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $207,478 - $250,812
-5,606 Reduced 1.95%
282,037 $10.5 Million
Q2 2021

Sep 13, 2021

BUY
$37.95 - $49.37 $10.9 Million - $14.2 Million
287,643 New
287,643 $12.2 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.43B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.